Agreement includes approximately $350 million in cash and upfront technology license fees for Evotec’s continuous manufacturing platform.
Kuvalanka brings over 20 years of experience in biopharmaceutical leadership, including finance, business development, and corporate strategy.
Ailux has announced a strategic collaboration with Eli Lilly and Company to accelerate the discovery and development of bispecific antibodies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback